Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Nature Protocols|April 3, 2007
Protocol for the MPTP mouse model of Parkinson's diseaseVernice Jackson-Lewis, Serge PrzedborskiBrain Research. Molecular Brain Research|March 26, 2005
The MPTP model of Parkinson's diseaseRichard Jay Smeyne, Vernice Jackson-LewisParkinsonism & Related Disorders|December 15, 2011
Animal models of Parkinson's diseaseVernice Jackson-Lewis, Javier Blesa, Serge PrzedborskiBiofactors (Oxford, England)|December 30, 2003
Primary coenzyme Q10 deficiency and the brainAli Naini, Vernice-Jackson Lewis, Michio Hirano, et al.Journal of Biomedicine & Biotechnology|April 27, 2012
Classic and new animal models of Parkinson's diseaseJavier Blesa, Sudarshan Phani, Vernice Jackson-Lewis, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 22, 2010
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's diseaseCristina Malagelada, Zong Hao Jin, Vernice Jackson-Lewis, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 29, 2006
RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivationCristina Malagelada, Elizabeth J Ryu, Subhas C Biswas, et al.Restorative Neurology and Neuroscience|April 3, 2003
The parkinsonian toxin MPTP: action and mechanismSerge Przedborski, Vernice Jackson-Lewis, Ruth Djaldetti, et al.Annals of Neurology|August 10, 2010
Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxinsCeline Perier, Jordi Bové, Benjamin Dehay, et al.Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseDu-Chu Wu, Peter Teismann, Kim Tieu, et al.Pageof 5